The Enterprise Value as of September 2024 (TTM) for Oncternal Therapeutics, Inc. (ONCT) is -1796314.00

According to Oncternal Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -1796314.00. This represents a change of -111.16% compared to the average of 16.09M of the last 4 quarters.

Oncternal Therapeutics, Inc. (ONCT) Historical Enterprise Value (quarterly & annually)

How has ONCT Enterprise Value performed in the past?

The mean historical Enterprise Value of Oncternal Therapeutics, Inc. over the last ten years is 952.23M. The current -1796314.00 Enterprise Value has changed -118.86% with respect to the historical average. Over the past ten years (40 quarters), ONCT's Enterprise Value was at its highest in in the March 2021 quarter at 8.06B. The Enterprise Value was at its lowest in in the September 2023 quarter at 3.11M.

Oncternal Therapeutics, Inc. (ONCT) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Oncternal Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Oncternal Therapeutics, Inc. (ONCT) Average Enterprise Value

How has ONCT Enterprise Value performed in the past?

The current Enterprise Value of Oncternal Therapeutics, Inc. (ONCT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Oncternal Therapeutics, Inc. (ONCT) Enterprise Value vs. Peers

How is ONCT’s Enterprise Value compared to its peers?

Oncternal Therapeutics, Inc.’s Enterprise Value is less than Neoleukin Therapeutics, Inc. (0), greater than CytomX Therapeutics, Inc. (-6333315.00), less than Assembly Biosciences, Inc. (63.41M), less than Instil Bio, Inc. (96.95M), less than Nuvation Bio Inc. (495.08M), less than Protara Therapeutics, Inc. (1.02B), greater than Vaccinex, Inc. (-46638168.00), less than Monopar Therapeutics Inc. (9.60M), less than Miromatrix Medical Inc. (9.21M), less than Surrozen, Inc. (90.06M), greater than Passage Bio, Inc. (-8605743.00), less than Absci Corporation (47.09M), less than Adverum Biotechnologies, Inc. (390.51M), less than Kezar Life Sciences, Inc. (96.85M), less than Armata Pharmaceuticals, Inc. (30.98M), less than Pasithea Therapeutics Corp. (198.61M), greater than Aditxt, Inc. (-3893252.00), less than null (10.40M),

Build a custom stock screener for Oncternal Therapeutics, Inc. (ONCT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Oncternal Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Oncternal Therapeutics, Inc. (ONCT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Oncternal Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.